Our medicines Our science Our stories

Skip to main content

Contact us Careers

Americas

Argentina

Spanish

Brazil

Portuguese

Canada

English / French

Chile

Spanish

Colombia

Spanish

Mexico

Spanish

Peru

Spanish

United States

English

Asia Pacific

Australia

English

China

Simplified Chinese

India

English

Japan

Japanese

Korea

Korean

New Zealand

English

Singapore

English

Taiwan

Traditional Chinese

Thailand

Europe

Austria

German

Belgium

English / Dutch / French

Czech Republic

Czech

Denmark

Danish

Finland

Finnish

France

French

Germany

German

Greece

Greek

Hungary

Hungarian

Ireland

English

Italy

Italian

Luxembourg

English

Netherlands

English / Dutch

Norway

Norwegian

Poland

Polish

Portugal

Portuguese

Romania

Romanian

Spain

Spanish

Sweden

Swedish

Switzerland

German / French

United Kingdom

English

Middle East

Israel

Hebrew

Saudi Arabia

English / Arabic

Turkey

Turkish

United Arab Emirates

English / Arabic

Other

Other Markets

Distributor Markets

bmsUScqPageLucene

Medicines
Careers
Press Releases
Medical Information

Our Medicines

Patients & caregivers

Our medicines

Survivorship Today

Patient resources

Get help paying for your medicines

Risk evaluation and mitigation strategies (REMS)

Plain language summaries of clinical trial results

CAR T cell therapy patient resources

Related links

Immunology patient resources

Our position on generic drugs

Our position on drug pricing

Psoriasis around the world

Healthcare providers

Learn about pre-approval access

Learn about post study drug access

340B practice fact sheet

DoctoRx Unscripted

Related links

U.S. medical information

Clinical trials

Researchers

Areas of focus

In the pipeline

R&D expert voices

Clinical trials & research

Independent research

Patient safety

Related links

Research publications

Disclosure commitment

Areas of interest & research grants

Data sharing request process

Translational medicine

Investors

Stock information

Financial reporting

Analyst coverage

Events and presentations

Shareholder services

Acquisition-related information for Celgene shareholders

Investor contacts

Related links

Annual reports

Dividend history

Investment return calculator

SEC filings

Quarterly results

Business development

Our partnerships

Why partner with us

Areas of interest

Business development leadership team

Early innovation at BMS

Contact Business Development

Related links

Download business development brochure

Doing business with us as a supplier

News & media

Press releases

Our stories

Media library

Media contacts

Related links

Scientific media resources

Disease state resources

Corporate resources

About us

Our company

Leadership

Our science

Global Inclusion & Diversity

Our impact

Working at BMS

Contact us

Related links

Global Patient Week

Our technologies

Our history

Our locations

The Bristol Myers Squibb Foundation

Resource groups

Our positions

Corporate resources

Find Bristol Myers Squibb's official logo, signage and video for media use, along with other resources.

Home
News and media
Media library
Corporate resources

LinkedIn
X
Facebook
Email

Corporate publications and resources

Annual reports

Annual reports

Global access report

Global access report

Environmental, social and governance report

Tabitha with her child

Our commitment to global inclusion and
diversity

Our principles

Our principles

To refine search, choose a category or topic and click on the search icon.

Search by

Category

Select All Clear

Corporate resources

Disease state resources

Scientific media resources

Topic

Select All Clear

Alzheimer’s disease

Atopic dermatitis

Atrial fibrillation

Biomarker

Cancer

Cancer research

Cardiomyopathy

Cardiovascular research

Cell therapy

Drug development

Drug discovery

Eosinophilic esophagitis

Genitourinary cancers

Health equity

Immune pathway

Immune-mediated

Immuno-oncology

Immunotherapy

Inflammatory bowel disease

Liver disease

Media asset

Protein degradation

Psoriasis

Pulmonary fibrosis

Radiopharmaceuticals

Rheumatoid arthrtis

Schizophrenia

Sjögren's disease

Thalassemia

Translational medicine

Sorry! No results were found

<< <

1

> >>

Main navigation

Sitemap
Home
Patients & caregivers
Healthcare providers
Researchers
Investors
News & media
About us

Resources

Our medicines
Legal notice
Privacy notice center
Trademarks
Forward-looking statement
BMS Modern Slavery Statement (PDF)

Follow us

Careers
Our stories
Contact us
Worldwide locations

May 14, 2025

© 2025 Bristol-Myers Squibb Company